Bamlanivimab (Synonyms: Anti-Human SARS-CoV-2) |
| Catalog No.GC68722 |
Bamlanivimab (Anti-Human SARS-CoV-2)는 2020년 11월 미국 식품의약국(FDA) 긴급사용승인(EUA)을 받은 COVID-19 단일 클론 항체(mAb) 중 첫 번째 제품입니다. 그러나 Bamlanivimab 내성을 가진 SARS-CoV-2 바이러스 변종이 증가함에 따라, Bamlanivimab은 2021년 4월에 철회되었습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2423943-37-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Bamlanivimab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Bamlanivimab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *